Acadia Healthcare Company, Inc. reported a revenue increase of 5.0% for the fiscal year ending December 31, 2025, totaling $3.31 billion, compared to $3.15 billion in 2024. The growth was driven by a 2.3% rise in admissions and a 2.1% increase in patient days, reflecting ongoing demand for its behavioral healthcare services. However, the company faced significant challenges, including a net loss of approximately $1.1 billion, largely attributed to a $1.01 billion impairment charge related to goodwill and other assets. This marked a stark contrast to the previous year's net income of $255.6 million.
In terms of operational changes, Acadia expanded its capacity by adding 1,089 beds across its facilities, which included 778 beds from new joint venture facilities and 311 beds added to existing locations. The company now operates 277 facilities with over 12,500 beds across 40 states and Puerto Rico. The strategic focus on joint ventures and new facility openings is part of Acadia's broader strategy to enhance its service offerings and market presence in a fragmented industry.
Financially, Acadia's total debt stood at approximately $2.5 billion as of December 31, 2025, with a significant portion tied to a new credit facility established in February 2025. This facility includes a $1 billion revolving credit line and a $650 million term loan, both maturing in 2030. The company reported interest expenses of $138.9 million for the year, up from $116.4 million in 2024, reflecting increased borrowings. Despite these challenges, Acadia maintained compliance with its financial covenants, with a consolidated total net leverage ratio of 4.0x.
The company’s revenue sources remained diverse, with 57.7% derived from Medicaid, 24.6% from commercial payors, and 14.3% from Medicare. This diversified payor mix helps mitigate risks associated with changes in reimbursement policies. However, Acadia anticipates potential impacts from recent legislative changes, including the One Big Beautiful Bill Act, which may tighten Medicaid eligibility and reduce federal expenditures, potentially affecting future revenue streams.
Looking ahead, Acadia's management remains optimistic about the demand for behavioral healthcare services, driven by increasing awareness of mental health issues and evolving healthcare legislation. The company plans to continue its growth strategy through facility expansions, joint ventures, and acquisitions, while also focusing on improving operational efficiencies to enhance profitability in a challenging economic environment.
About Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. operates a nationwide network of behavioral healthcare facilities, including acute inpatient psychiatric hospitals, specialty treatment centers, comprehensive treatment centers, and residential treatment centers. Serving patients with complex mental health and substance use disorders, Acadia provides a continuum of care through medical, therapeutic, and medication-assisted treatments. Its diversified revenue base includes Medicaid, Medicare, and commercial payors, supported by a scalable business model focused on facility ownership, partnerships, and acquisitions.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.